Laparoscopic hepatectomy reduces postoperative complications and hospital stay in overweight and obese patients

Table 1 Patients’ characteristics in the overweight and obese group (body mass index 25 kg/m²)

	LH vs OH
	LH cohort (n = 68)	OH cohort (n = 68)	P value
Demographics
Sex, n (%)			0.116
Male	36 (52.9)	45 (66.2)
Female	32 (47.1)	23 (33.8)
Age (yr)	64.4 ± 10.2	64.5 ± 12.3	0.812
BMI (kg/m2)	29.8 ± 4.9	29.7 ± 3.6	0.463
Diagnosis, n (%)			0.777
LM	41 (60.3)	42 (61.8)
HCC	20 (29.4)	17 (25.0)
iCC	7 (10.3)	9 (13.2)
ASA, n (%)			0.328
I	0	0
II	28 (41.2)	24 (35.3)
III	35 (51.5)	42 (61.8)
IV	5 (7.4)	2 (2.9)
V	0	0
Previous abdominal surgery, n (%)	23 (33.8)	26 (38.2)	0.592
Clinical characteristics
Steatosis, n (%)	20 (29.4)	21 (30.9)	0.852
Fibrosis, n (%)	21 (30.9)	8 (11.8)	0.006
Cirrhosis, n (%)	9 (13.2)	12 (17.6)	0.477
Albumin (g/dL)	4.4 ± 0.4	3.6 ± 0.7	< 0.001
GGT (U/L)	85.1 ± 104.2	119.2 ± 219.0	0.326
Total bilirubin (mg/dL)	0.4 ± 0.3	0.9 ± 0.6	< 0.001
Platelet count (/nL)	254.0 ± 85.4	230.9 ± 90.5	0.135
Alkaline phosphatase (U/L)	85.1 ± 34.2	93.8 ± 84.2	0.584
INR	0.98 ± 0.08	1.06 ± 0.07	< 0.001
Hemoglobin (g/dL)	13.3 ± 1.7	13.6 ± 4.1	0.984

LH: Laparoscopic hepatectomy; OH: Open hepatectomy; BMI: Body mass index; LM: Liver metastasis; HCC: Hepatocellular carcinoma; iCC: intrahepatic cholangiocellular carcinoma; GGT: Gamma-glutamyl transpeptidase.